Integrated Annual Report

Overview

The report presents Ipsen's 2024 performance, including €3.4 billion in total sales, four new medicine launches and continued pipeline expansion. It highlights completion of a double materiality assessment and ambitions for a 50% absolute Scope 1 and 2 reduction by 2030 and net-zero carbon emissions by 2045. The sustainability section reports a 45% reduction in absolute Scope 1 and 2 emissions, a 25% reduction in absolute Scope 3 emissions and 99.8% renewable electricity. It also describes Board-level CSR oversight and a Board comprising seven women and seven men.

Document

Report type: Integrated Report
Class: Embedded
Scope: Full report
Fiscal year: 2024
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services